Gilotra NA, Russell SD. Arginine vasopressin as a target in the treatment of acute heart failure. World J Cardiol 2014; 6(12): 1252-1261 [PMID: 25548615 DOI: 10.4330/wjc.v6.i12.1252]
Corresponding Author of This Article
Stuart D Russell, MD, Associate Professor of Medicine, Chief, Advanced Heart Failure and Transplant, Division of Cardiology, Johns Hopkins Hospital, 1800 Orleans Street, Sheikh Zayed Tower, Suite 7125, Baltimore, MD 21287, United States. srusse14@jhmi.edu
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/